Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
$1.12
$2.76
$0.71
$6.41
$65.20MN/A214,681 shsN/A
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
$0.00
$0.03
$6.74
$4.17M0.457.75 million shsN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$20.71
-3.3%
$18.97
$10.31
$21.45
$621.51M2.06142,573 shs221,376 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
0.00%0.00%0.00%0.00%+38.27%
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
0.00%0.00%0.00%-99.32%-98.75%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
+2.73%+7.05%+8.73%+38.02%+58.55%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/AN/AN/AN/AN/AN/AN/AN/A
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.2398 of 5 stars
1.34.00.00.01.82.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/AN/AN/AN/A
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.67
Moderate Buy$18.75-9.46% Downside

Current Analyst Ratings

Latest FTRP, PEAR, and PNTG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$18.00 ➝ $22.00
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$16.00 ➝ $21.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
$3.88M16.80N/AN/A$0.92 per share1.22
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
$12.69M0.00N/AN/A$0.22 per share0.00
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$544.89M1.14$0.78 per share26.65$4.86 per share4.26

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
-$43.63M-$0.77N/AN/AN/A-1,125.12%-62.71%-47.29%N/A
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
-$75.49M-$0.22N/AN/AN/A-594.70%-217.85%-95.20%N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$13.38M$0.4447.0724.082.202.46%12.78%3.36%5/6/2024 (Confirmed)

Latest FTRP, PEAR, and PNTG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$0.15N/A-$0.15N/AN/AN/A  
2/28/202412/31/2023
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$0.19$0.18-$0.01$0.22$136.79 million$145.95 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/AN/AN/AN/AN/A
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
0.40
8.20
8.20
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/A
1.48
1.48
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
0.44
1.12
1.12

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
16.84%
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
71.17%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
85.88%

Insider Ownership

CompanyInsider Ownership
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/A
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
30.70%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
10458.22 millionN/ANot Optionable
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
300142.74 million98.92 millionNot Optionable
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5,79130.01 million28.63 millionOptionable

FTRP, PEAR, and PNTG Headlines

SourceHeadline
Pennant Announces First Quarter 2024 Earnings Release and CallPennant Announces First Quarter 2024 Earnings Release and Call
globenewswire.com - April 23 at 4:02 PM
The Pennant Group, Inc. (PNTG)The Pennant Group, Inc. (PNTG)
finance.yahoo.com - April 23 at 9:01 AM
The Pennant Group (NASDAQ:PNTG) Reaches New 12-Month High at $21.00The Pennant Group (NASDAQ:PNTG) Reaches New 12-Month High at $21.00
marketbeat.com - April 22 at 4:46 PM
Cornercap Investment Counsel Inc. Acquires Shares of 42,851 The Pennant Group, Inc. (NASDAQ:PNTG)Cornercap Investment Counsel Inc. Acquires Shares of 42,851 The Pennant Group, Inc. (NASDAQ:PNTG)
marketbeat.com - April 17 at 6:45 AM
What Makes The Pennant Group, Inc. (PNTG) a Strong Momentum Stock: Buy Now?What Makes The Pennant Group, Inc. (PNTG) a Strong Momentum Stock: Buy Now?
zacks.com - April 8 at 1:01 PM
The Pennant Group (NASDAQ:PNTG) Hits New 12-Month High at $20.54The Pennant Group (NASDAQ:PNTG) Hits New 12-Month High at $20.54
marketbeat.com - April 3 at 4:51 PM
The Pennant Group, Inc. (NASDAQ:PNTG) Short Interest Up 27.5% in MarchThe Pennant Group, Inc. (NASDAQ:PNTG) Short Interest Up 27.5% in March
marketbeat.com - April 1 at 3:48 PM
The Pennant Group, Inc.s (NASDAQ:PNTG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?The Pennant Group, Inc.'s (NASDAQ:PNTG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
finance.yahoo.com - March 28 at 11:12 AM
PNTG May 2024 17.500 putPNTG May 2024 17.500 put
finance.yahoo.com - March 26 at 2:07 PM
Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services ConferencePennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
globenewswire.com - March 12 at 11:22 AM
Heres Why The Pennant Group, Inc. (PNTG) is a Great Momentum Stock to BuyHere's Why The Pennant Group, Inc. (PNTG) is a Great Momentum Stock to Buy
zacks.com - March 7 at 1:01 PM
What Makes The Pennant Group, Inc. (PNTG) a New Buy StockWhat Makes The Pennant Group, Inc. (PNTG) a New Buy Stock
zacks.com - March 5 at 1:01 PM
Earnings call: Pennant Group exceeds Q4 earnings, eyes growth in 2024Earnings call: Pennant Group exceeds Q4 earnings, eyes growth in 2024
investing.com - March 2 at 11:41 PM
Pennant Group, Inc. (PNTG) Q4 2023 Earnings Call TranscriptPennant Group, Inc. (PNTG) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 2 at 6:40 PM
Pennant Group, Inc.: Pennant Reports Fourth Quarter and Fiscal Year 2023 ResultsPennant Group, Inc.: Pennant Reports Fourth Quarter and Fiscal Year 2023 Results
finanznachrichten.de - March 1 at 5:36 PM
Pennant Acquires Two Senior Living Communities in UtahPennant Acquires Two Senior Living Communities in Utah
globenewswire.com - March 1 at 3:58 PM
The Pennant Group, Inc. (NASDAQ:PNTG) Q4 2023 Earnings Call TranscriptThe Pennant Group, Inc. (NASDAQ:PNTG) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 1 at 12:36 PM
Pennant Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsPennant Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
finance.yahoo.com - March 1 at 7:35 AM
The Pennant Group, Inc. (PNTG) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesThe Pennant Group, Inc. (PNTG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - February 28 at 7:31 PM
Pennant Group Inc (PNTG) Reports Strong Earnings Growth in Q4 and Fiscal Year 2023Pennant Group Inc (PNTG) Reports Strong Earnings Growth in Q4 and Fiscal Year 2023
ca.finance.yahoo.com - February 28 at 5:55 PM
Pennant GAAP EPS of $0.14 misses by $0.06, revenue of $146M beats by $9.57MPennant GAAP EPS of $0.14 misses by $0.06, revenue of $146M beats by $9.57M
msn.com - February 28 at 5:55 PM
Pennant Reports Fourth Quarter and Fiscal Year 2023 ResultsPennant Reports Fourth Quarter and Fiscal Year 2023 Results
globenewswire.com - February 28 at 4:05 PM
Ahead of The Pennant Group, Inc. (PNTG) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsAhead of The Pennant Group, Inc. (PNTG) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
zacks.com - February 26 at 10:21 AM
Pennant Announces Fourth Quarter and Year-End 2023 Earnings Release and CallPennant Announces Fourth Quarter and Year-End 2023 Earnings Release and Call
finance.yahoo.com - February 14 at 8:13 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Field Trip Health logo

Field Trip Health

NASDAQ:FTRP
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
Pear Therapeutics logo

Pear Therapeutics

NASDAQ:PEAR
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
The Pennant Group logo

The Pennant Group

NASDAQ:PNTG
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.